(Q38007987)

26 August 2017

1 reference

title

Cushing's syndrome: a review of diagnostic tests (English)

1 reference

26 August 2017

Cushing's syndrome: A review of diagnostic tests (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

17 January 2023

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

17 January 2023

author name string

L. Crapo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A225638

17 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=225638

17 January 2023

publication date

1 September 1979

1 reference

full work available at URL

26 August 2017

https://api.elsevier.com/content/article/PII:0026049579900970?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

https://api.elsevier.com/content/article/PII:0026049579900970?httpAccept=text/plain

17 January 2023

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

17 January 2023

1 reference

26 August 2017

28

1 reference

26 August 2017

955-977

1 reference

26 August 2017

9

1 reference

PROBABILITY THEORY IN THE DIAGNOSIS OF CUSHING'S SYNDROME

26 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The production rate of cortisol in man

17 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

On Cortisol Production Rate

17 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Further Studies of Cortisol Production Rate

17 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Studies of hydrocortisone production as measured by isotope dilution techniques in adrenocortical diseases and in idiopathic hirsutism

17 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

In vivo and in vitro studies of adrenal secretions in Cushing's syndrome and primary aldosteronism

17 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

APPRAISAL OF ADRENOCORTICAL HYPERFUNCTION: PATIENTS WITH CUSHING'S SYNDROME OR "NON-ENDOCRINE" TUMORS

17 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing's syndrome

17 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

CLINICAL VALUE OF THE CORTISOL SECRETION RATE.

17 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Diagnostic value of the simultaneous determination of urinary free and conjugated cortisol in Cushing's syndrome

17 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The Diagnosis of Hypercortisolism. Biochemical Criteria Differentiating Patients from Lean and Obese Normal Subjects and from Females on Oral Contraceptives

17 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome

17 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Chemical method for the determination of 17-hydroxycorticosteroids and 17-ketosteroids in urine following hydrolysis with beta-glucuronidase

17 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine.

17 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Indirect analysis of corticosteroids. I. The determination of 17-hydroxycorticosteroids

17 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Determination of urinary 17-ketogenic steroids by means of sodium metaperiodate oxidation

17 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The reliability of some adrenal function tests.

17 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Clinical evaluation of urinary cortisol determinations by competetive protein-binding radioassay

17 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome.

17 January 2023

24

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

DETERMINATION OF URINARY UNCONJUGAT- ED CORTISOL BY GLASS FIBER CHROMATOGRAPHY IN THE DIAGNOSIS OF CUSHING'S SYNDROME

17 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Steroid excretion and plasma cortisol in 41 cases of Cushing's syndrome. With data on corticotrophin and metapyron tests.

17 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Patterns of urinary excretion of steroids in Cushing's syndrome

17 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome

17 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cushing's syndrome: A prospective study of diagnostic methods

17 January 2023

31

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Adrenocortical function in obesity and Cushing's syndrome

17 January 2023

32

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

An evaluation of laboratory tests for the detection and differential diagnosis of Cushing's syndrome

17 January 2023

33

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Surgical experience with Cushing's disease

17 January 2023

34

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas

17 January 2023

35

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

URINARY CORTISOL EXCRETION AS A TEST OF ADRENAL CORTICAL FUNCTION

17 January 2023

36

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Urinary excretion of cortisol in Cushing's syndrome: effect of corticotropin

17 January 2023

40

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Urinary cortisol excretion in stress situations and in patients with Cushing's syndrome

17 January 2023

41

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A method for the determination of 17-hydroxycorticosteroids in blood; 17-hydroxycorticosterone in the peripheral circulation

17 January 2023

42

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Determination of 17, 21-dihydroxy-20-ketosteroids in blood plasma

17 January 2023

43

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Fluorimetric determination of free plasma 11-hydroxycorticosteroids in man

17 January 2023

45

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma

17 January 2023

46

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The determination of adrenocortical steroids in blood: observations on the reliability of a simple fluorimetric method for cortisol

17 January 2023

47

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Simple method for the determination of plasma corticoids

17 January 2023

48

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cortisol is secreted episodically by normal man.

17 January 2023

50

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

ACTH and cortisol secretory patterns in man

17 January 2023

51

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Characterization of the normal temporal pattern of plasma corticosteroid levels.

17 January 2023

52

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Episodic Variation in Plasma Corticosteroids in Subjects with Cushing's Syndrome of Differing Etiology

17 January 2023

53

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Simultaneous measurement of multiple plasma steroids by radioimmunoassay demonstrating episodic secretion

17 January 2023

54

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Simultaneous study of cortisol and TSH daily variations in normal subjects and patients with hyperadrenalcorticism.

17 January 2023

55

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cortisol is secreted episodically in Cushing's syndrome

17 January 2023

56

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Repeated Plasma Cortisol Determinations in Cushing's Syndrome Due to Adrenocortical Adenoma

17 January 2023

57

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Short-term fluctuations in plasma cortisol in Cushing's syndrome

17 January 2023

58

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The diurnal variation of plasma levels and urinary excretion on 17-hydroxycorticosteroids in normal subjects, night workers and blind subjects

17 January 2023

59

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Studies of the diurnal variation of plasma 17-hydroxycorticosteroids in man

17 January 2023

60

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma 17-hydroxycorticosteroids in Cushing's syndrome

17 January 2023

61

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Circadian rhythm of plasma 11-hydroxycorticosteroids in depressive illness, congestive heart failure, and Cushing's syndrome.

17 January 2023

63

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Concentration of corticosterone and cortisol in peripheral plasma of patients with adrenocortical hyperplasia and normal subjects

17 January 2023

64

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Alcohol-induced Cushingoid syndrome

17 January 2023

67

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Alcohol-induced pseudo-Cushing's syndrome

17 January 2023

68

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma-cortisol response to lysine-vasopressin. Comparison with other tests of human pituitary-adrenocortical function.

17 January 2023

69

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects

17 January 2023

70

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Evaluation of three acute tests of hypothalamic-pituitary-adrenal function

17 January 2023

73

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A fundamental defect of adrenocortical control in Cushing's disease.

17 January 2023

75

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Pituitary response to stress in Cushing's disease

17 January 2023

76

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome.

17 January 2023

78

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Radioimmunoassay of plasma adrenocorticotrophin in Cushing's syndrome

17 January 2023

79

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma ACTH and Cortisol Responses to TRF, Vasopressin or Hypoglycemia in Cushing's Disease and Nelson′s Syndrome

17 January 2023

80

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Pituitary-adrenal function in severe depressive illness.

17 January 2023

81

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

DIAGNOSIS OF CUSHING'S SYNDROME; SINGLE DOSE DEXAMETHASONE SUPPRESSION TEST

17 January 2023

82

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A RAPID SCREENING TEST FOR CUSHING'S SYNDROME

17 January 2023

83

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Rapid Dexamethasone Suppression Test for Cushing's Syndrome

17 January 2023

84

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Singledose dexamethasone suppression test for Cushing's Syndrome

17 January 2023

86

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Single-dose dexamethasone suppression in normal subjects and hospital patients

17 January 2023

87

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Simplified dexamethasone suppression test

17 January 2023

88

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Experience with a short test of pituitary-adrenal function.

17 January 2023

89

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A Rapid Screening Test for Cushing's Syndrome

17 January 2023

90

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Conjugated estrogens and the overnight dexamethasone suppression test

17 January 2023

91

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome

17 January 2023

92

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cushing's syndrome in childhood: report of two cases with bilateral adrenocortical hyperplasia, showing distinctive clinical features

17 January 2023

93

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cure of Cushing's Disease by Transsphenoidal Removal of a Microadenoma from a Pituitary Gland Despite a Radiographically Normal Sella Turcica

17 January 2023

95

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

“Normal Suppression” to Dexamethasone in Cushing's Disease: An Expression of Decreased Metabolic Clearance for Dexamethasone

17 January 2023

96

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

An Unusual Case of Cushing's Syndrome

17 January 2023

97

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

ADRENAL FUNCTION AND THE COMPLICATIONS OF DIABETES MELLITUS.

17 January 2023

98

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Measurement of plasma cortisol in the diagnosis of Cushing's syndrome

17 January 2023

99

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Effect of diphenylhydantoin on the metabolism of dexamethasone

17 January 2023

100

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

17 January 2023

Lung cancer and surgery

101

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Results of treatment in 108 patients with Cushing's syndrome.

17 January 2023

104

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease

17 January 2023

106

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Dexamethasone-suppressible adrenocortical tumor.

17 January 2023

107

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

ACTH-responsive, dexamethasone-suppressible adrenocortical carcinoma.

17 January 2023

108

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Diagnosis and treatment of Cushing's syndrome

17 January 2023

109

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

CUSHING'S SYNDROME WITH ATYPICAL BIOCHEMICAL RESULTS

17 January 2023

110

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Observations and comments on failure of dexamethasone suppression

17 January 2023

111

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The New England Journal of Medicine

17 January 2023

112

277

431

1967

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.

17 January 2023

113

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Periodic hormonogenesis--a new phenomenon. Periodicity in function of a hormone-producing tumor in man

17 January 2023

114

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone

17 January 2023

115

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Periodic Remission in Cushing's Disease with Paradoxical Dexamethasone Response: An Expression of Periodic Hormonogenesis

17 January 2023

116

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

ACTH and MSH assays and their clinical application

17 January 2023

119

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The impact of radioimmunoassay on our understanding of human adrenal physiology

17 January 2023

120

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

ACTH, lipotrophin and MSH in health and disease

17 January 2023

121

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary Gland

17 January 2023

122

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor

17 January 2023

123

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Common precursor to corticotropins and endorphins

17 January 2023

125

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

High molecular weight forms of human ACTH are glycoproteins

17 January 2023

126

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Radioimmunoassay of beta-MSH in human plasma and tissues

17 January 2023

127

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Normal and abnormal regulation of beta-msh in man.

17 January 2023

128

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma immunoreactive corticotrophin and lipotrophin in Cushing's syndrome and Addison's disease

17 January 2023

129

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Human plasma immunoreactive β-lipotropin: Correlation with basal and stimulated plasma ACTH concentrations

17 January 2023

130

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Diurnal Rhythm and Disappearance Half-Time of Endogenous Plasma Immunoreactive β-MSH (LPH) and ACTH in Man*

17 January 2023

131

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A Specific Radioimmunoassay for Human β-Lipotropin*

17 January 2023

132

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man.

17 January 2023

133

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A comparison of bioassay and radioimmunoassay for plasma corticotropin in man.

17 January 2023

134

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Relationship of Bioassayable and Immunoassayable Plasma ACTH and Cortisol Concentrations in Normal Subjects and in Patients with Cushing's Disease

17 January 2023

135

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A Sensitive Biologic Assay for ACTH

17 January 2023

137

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Blood corticotropin (ACTH) levels in Cushing's disease

17 January 2023

138

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cause of Cushing's Syndrome in Patients with Tumors Arising from “Nonendocrine” Tissue

17 January 2023

139

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Adrenocorticotropic hormone in human plasma

17 January 2023

140

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

CORRELATION OF PLASMA ACTH CONCENTRATION WITH ADRENOCORTICAL RESPONSE IN NORMAL HUMAN SUBJECTS, SURGICAL PATIENTS, AND PATIENTS WITH CUSHING'S DISEASE

17 January 2023

141

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Nonpituitary neoplasms and Cushing's syndrome. Ectopic "adrenocorticotropin" produced by nonpituitary neoplasms as a cause of Cushing's syndrome

17 January 2023

142

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma ACTH determinations in 58 patients before or after adrenalectomy for Cushing's syndrome.

17 January 2023

143

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Studies of ACTH Secretion Control in 116 Cases of Cushing's Syndrome

17 January 2023

144

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Radioreceptor assay of adrenocorticotropic hormone: new approach to assay of polypeptide hormones in plasma

17 January 2023

145

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Adrenocorticotropin measurement by competitive binding receptor assay

17 January 2023

146

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Isolated adrenal cortex cells: hypersensitivity to adrenocorticotropic hormone after hypophysectomy.

17 January 2023

147

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A Sensitive Bioassay for the Determination of Human Plasma ACTH Levels

17 January 2023

148

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A sensitive bioassay for adrenocorticotrophic hormone in human plasma.

17 January 2023

149

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Comparison of the redox assay for ACTH with previous assays

17 January 2023

150

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Circulating corticotrophin levels in severe hypopituitarism and in the neonate.

17 January 2023

151

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

General introduction to cytochemical hormone bioassay

17 January 2023

152

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The cytochemical bioassay of corticotrophin.

17 January 2023

153

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The cytochemical section assay for corticotrophin

17 January 2023

154

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Validation of the redox cytochemical assay for corticotrophin.

17 January 2023

155

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Application of the cytochemical bioassay for corticotrophin to clinical and physiological studies in man

17 January 2023

156

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Studies on the mechanism of cytochemical bioassays

17 January 2023

157

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Radioimmunoassay of ACTH in plasma

17 January 2023

158

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man

17 January 2023

161

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease

17 January 2023

163

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A sensitive radioimmunoassay for plasma ACTH levels.

17 January 2023

164

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma levels of immunoreactive corticotrophin in patients with Cushing's syndrome.

17 January 2023

165

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Tumor and plasma ACTH concentrations in patients with and without the ectopic ACTH syndrome

17 January 2023

166

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome

17 January 2023

167

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Tests in cushing's syndrome

17 January 2023

168

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A new phenomenon of usefulness in the radioimmunoassay of plasma adrenocorticotropic hormone

17 January 2023

169

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Preparation and evaluation of ACTH antibodies.

17 January 2023

171

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Application of Adrenocorticotropin Assays in a Routine Clinical Laboratory

17 January 2023

172

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Paradoxical ACTH Response to Glucocorticoids in Cushing's Disease

17 January 2023

173

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Treatment of Cushing's Syndrome with Trilostane (WIN 24,540), an Inhibitor of Adrenal Steroid Biosynthesis*

17 January 2023

174

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Selective Venous Sampling to Differentiate Ectopic ACTH Secretion from Pituitary Cushing's Syndrome

17 January 2023

175

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Secretion of ACTH and -MSH by an adrenal medullary paraganglioma

17 January 2023

176

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Dual Sites of Inhibition by Metyrapone of Human Adrenal Steroidogenesis: Correlation ofin Vivoand andin VitroStudies

17 January 2023

178

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11 beta-hydroxylation

17 January 2023

179

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Clinical application of a new test of pituitary reserve

17 January 2023

181

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Quantitation of the accelerating effect of metyrapone on cortisol metabolism

17 January 2023

182

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Extraadrenal Effects of Metyrapone in Man*

17 January 2023

183

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

An assessment of the metyrapone test.

17 January 2023

185

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Direct and indirect estimation of pituitary adrenocorticotropin reserves in man following adrenal steroid therapy.

17 January 2023

186

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

ASSESSMENT OF PITUITARY ACTH SECRETORY CAPACITY WITH METOPIRONE: 1. INTERPRETATION.

17 January 2023

189

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

FALSELY ABNORMAL RESPONSES OF NORMAL SUBJECTS TO THE METOPIRONE (SU-4885) TEST FOR PITUITARY ACTH RESERVE.

17 January 2023

190

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Partial pituitary ablation with implants of gold-198 and yttrium-90 for Cushing's syndrome with associated adrenal hyperplasia.

17 January 2023

192

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma

17 January 2023

193

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Clinical use of a new diagnostic agent, methopyrapone (SU-4885), in pituitary and adrenocortical disorders.

17 January 2023

195

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A test of pituitary reserve utilizing intravenous SU-4885, with a new method for extraction of 11-desoxvcorticosteroids.

17 January 2023

196

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The Metyrapone Test of Pituitary Function

17 January 2023

198

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma 11-deoxycorticosteroid and ACTH response to metyrapone (plasma metyrapone test).

17 January 2023

199

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A Simplified Metyrapone Test with Determination of Plasma 11-Deoxycortisol (Metyrapone Test with Plasma S)

17 January 2023

200

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.

17 January 2023

201

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Effect of estrogen on the metabolism of metyrapone and release of ACTH

17 January 2023

202

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Evaluation of single oral dose metyrapone tests in children with hypopituitarism

17 January 2023

204

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH

17 January 2023

206

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Single-dose metyrapone test: review of a four-year experience

17 January 2023

207

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Plasma 11-deoxycortisol radioimmunoassay for metyrapone tests.

17 January 2023

208

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Short time kinetics of deoxycorticosterone, deoxycortisol, corticosterone and cortisol during single dose metyrapone test

17 January 2023

209

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Single Dose Metyrapone Test: 11β-Hydroxylase Inhibition by Metyrapone and Reduced Metyrapone Assayed by Radioimmunoassay

17 January 2023

210

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Simplified assessment of pituitary-adrenal reserve. Measurement of serum 11-deoxycortisol and cortisol after metyrapone

17 January 2023

212

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Evaluation of 3 hour metyrapone test in children and adolescents

17 January 2023

213

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Advances in the diagnosis of altered states of adrenocortical function

17 January 2023

214

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Acute unilateral adrenal hemorrhage following ACTH administration in a patient with Cushing's syndrome

17 January 2023

215

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

17 January 2023

Adrenal venography

216

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Adrenal venography: clinical-roentgeno-graphic correlation in 80 patients.

17 January 2023

217

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Diagnosis of Adrenal Disease by Visualization of Human Adrenal Glands with131I-19-Iodocholesterol

17 January 2023

218

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans

17 January 2023

220

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

The pituitary fossa in Cushing's syndrome. A retrospective analysis of 93 patients.

17 January 2023

221

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

Transsphenoidal removal of pituitary microadenoma in Cushing's disease

17 January 2023

222

1 reference

https://api.crossref.org/works/10.1016/0026-0495(79)90097-0

17 January 2023

Identifiers

1 reference

26 August 2017

1 reference